Fundz

Cere Vasc, Inc. reported raising $11.1 Million in an initial SEC Form D filing, from an offering of $32.5 Million

PRIVATEJun 05, 2020$11.1M of $32.5M raised

Amount Raised

$11.1 Million

$11.1 Million sold, per SEC Form D (first sale Jun 5, 2020)

Round Type

Venture

BostonBiotechnology

Quick answer

CereVasc raised $11.1 Million in a funding round, dated June 5, 2020. CereVasc is based in Boston, Massachusetts, United States.

How much did CereVasc raise?
CereVasc raised $11.1 Million in a funding round on June 5, 2020.
What does CereVasc do?
Located in Massachusetts’ healthcare hub, CereVasc, Inc., is a clinical stage, medical device company focused on the development of novel, minimally invasive treatments for patients with neurological diseases.
Where is CereVasc based and how big is it?
CereVasc is based in Boston, Massachusetts, United States.
Who are the decision-makers at CereVasc?
Fundz holds 2 contacts at CereVasc, including the Senior Director, Marketing & Communications. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as CereVasc that raised within 45 days of this round, from Fundz verified event records.

  • CardioFocus, Inc. raised $12M on July 20, 2020.
  • S4 Medical Corp. raised $1.9M (Seed) on July 20, 2020.
  • NANO-C raised $1.3M (Seed) on July 20, 2020.
  • GreenMark Biomedical Inc. raised an undisclosed amount on July 17, 2020.
  • SAB Biotherapeutics raised an undisclosed amount (Series B) on July 17, 2020.
  • Amunix Pharmaceuticals, Inc. raised an undisclosed amount on July 17, 2020.

Who to call at CereVasc, and when

A new round usually means CereVasc is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day CereVasc raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at CereVasc, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at CereVasc. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

CereVasc

Location

2120 COMMONWEALTH AVE., SUITE 1

Boston, Massachusetts, United States

About

Located in Massachusetts’ healthcare hub, CereVasc, Inc., is a clinical stage, medical device company focused on the development of novel, minimally invasive treatments for patients with neurological diseases. Its initial product, the eShunt System, encompasses first-ever, groundbreaking percutaneous transvenous-transdural access to the central nervous system intended to allow the first minimally invasive treatment for communicating hydrocephalus (CH), a potential improvement to the current standard of care. The eShunt device concept originated from Tufts Medical Center physicians Carl Heilman, MD, Neurosurgeon-in-Chief and Chair of Neurosurgery, and Adel Malek, MD, PhD, Chief of Neurovascular Surgery and Director of Endovascular Neurosurgery. The patented eShunt System includes an endovascularly implantable cerebral spinal fluid shunt and delivery components, which are designed to treat CH without invasive surgery.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment CereVasc raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsTiffany W., Senior Director, Marketing & Communicat… hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for CereVasc's next move

See what Strategic adds

CereVasc raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.